Pathos AI raises $237 million, partners with Bristol Myers and Tempus
Pathos AI said Friday it raised $237 million led by Bristol Myers Squibb and will work with BMS and Tempus AI on neurological drug-development tools, according to CNA carrying Reuters.
How it’s being reported
1 sourcePathos AI teams up with Bristol Myers and Tempus AI to advance drug development
Gives this outlet’s account of the story.
Same copy also at: (Reuters, via CNA)